Who We Are
As the world's leading provider of generic drugs, Teva Pharmaceuticals understands the importance of making safe, quality medications accessible—and affordable. That's why we manufacture and market the most expansive portfolio of FDA-approved generic products in the United States and aggressively pursue new research and development efforts.1
One in eight of the 3.65 billion generic prescriptions written in the United States is filled with a Teva product.1 This makes better healthcare accessible to patients. Teva helped contribute to the $239 billon dollars in savings in U.S. healthcare by providing affordable generic drugs!2
Teva's extensive U.S. operations are headquartered outside of Philadelphia, Pa., and include more than 6,500 employees in more than 30 facilities across the United States and its Territories.3 Our generic products include a wide variety of therapeutic options, ranging from cardiovascular, anti-infective, central nervous system, anti-inflammatory, oncolytic, anti-diabetic, analgesic, dermatologic, respiratory, and women's health, with dosage forms including tablets, capsules, injectables, creams, ointments, inhalants, solutions, and suspensions.
Teva Pharmaceuticals USA is a wholly owned subsidiary of Israeli-based Teva Pharmaceutical Industries Ltd., the global leader in generics and one of the top 10 pharmaceutical companies in the world.
1. IMS Health NPA Data as of MAT June 2014
2. Generic Pharmaceutical Association. Generic Drug Savings in the U.S. Sixth Annual Edition: 2014. http://www.gphaonline.org/media/cms/2013_Savings_Study_12.19.2013_FINAL.pdf. Accessed January 15, 2014
3. Internal Data on File